Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Chembio ProciseDx Analyzer
SDP

Catalog No. 21010242
Change view
Click to view available options
Type:
Clinical Chemistry Analyzer
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Type
21-010-242 Clinical Chemistry Analyzer
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. 21-010-242 Supplier Chembio Supplier No. 4390US
Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy

ProciseDx™ Analyzer is the only FDA-cleared system for therapeutic drug monitoring of Infliximab and Adalimumab. It delivers rapid, quantitative serum results in under 5 minutes - helping clinical labs reduce send-outs, improve workflow, and support informed IBD care decisions.

  • FDA-Cleared for Therapeutic Drug Monitoring (TDM): The only FDA-cleared system for quantitative measurement of Infliximab (IFX) and Adalimumab (ADL) drug levels in human serum—supporting therapeutic management in adult and pediatric IBD patients.
  • Rapid Turnaround Time: Delivers quantitative results in under 5 minutes from sample insertion—enabling timely clinical decision-making and eliminating the delays of send-out testing.
  • Streamlined Workflow for Clinical Labs: Minimal hands-on time (~3 minutes) and no batching required. Simple, standardized protocol fits easily into daily operations with no calibration, no daily maintenance, and no special service contracts.
  • Compact, Bench-Top Design: Small footprint allows the ProciseDx Analyzer to fit seamlessly into hospital labs, specialty reference labs, and clinical testing sites without disrupting existing workflows.
  • High Precision and Proprietary Technology: Utilizes time-resolved fluorescence energy transfer (TR-FRET) for accurate, reproducible results. Delivers performance comparable to laboratory-developed methods (LDTs) in a validated, FDA-cleared format.
  • Supports Both Adult and Pediatric IBD Patients: Validated for use in both populations, ensuring broad clinical applicability across a range of GI care settings.
  • Full System Offering: Includes the ProciseDx™ Analyzer and FDA-cleared Procise IFX and ADL assays. Each component is designed to work together as a fully integrated platform.

Specifications

Type Clinical Chemistry Analyzer
Sample Type Serum
Shipping Condition -4°F to +131°F (-20°C to +55°C)
Voltage 100/240 V
Weight (English) 10 lb.
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.